Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany

Charles Christian Adarkwah, Afschin Gandjour

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)62-70
JournalInternational Journal of Technology Assessment in Health Care
Volume26
Issue number1
DOIs
Publication statusPublished - Jan 2010

Keywords

  • Type 2 diabetes mellitus
  • Cost-effectiveness
  • Decision modeling
  • Angiotensin-converting enzyme inhibitors
  • Angiotensin II receptor blockers
  • Screening

Cite this